Quarterly Call Option Transactions in Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO) during . The information is specifically focused on institutions that hold call options of Akero Therapeutics, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | — | — | 0 | |||||
| Q4 2021 | — | — | 0 | |||||
| Q1 2022 | — | — | 0 | |||||
| Q2 2022 | — | 3,200 | 0 | 3,200 | -3,200 | |||
| Q3 2022 | 154,500 | 356,700 | 511,200 | 22,300 | 0 | 22,300 | 488,900 | |
| Q4 2022 | 332,900 | 177,400 | 510,300 | 69,800 | 0 | 69,800 | 440,500 | |
| Q1 2023 | 23,200 | 106,800 | 130,000 | 253,500 | 7,700 | 261,200 | -131,200 | |
| Q2 2023 | 43,900 | 369,000 | 412,900 | 56,400 | 0 | 56,400 | 356,500 | |
| Q3 2023 | 337,400 | 1,809,389 | 2,146,789 | 99,900 | 0 | 99,900 | 2,046,889 | |
| Q4 2023 | 431,000 | 16,600 | 447,600 | 207,100 | 0 | 207,100 | 240,500 | |
| Q1 2024 | 22,600 | 105,000 | 127,600 | 493,700 | 0 | 493,700 | -366,100 | |
| Q2 2024 | — | 73,700 | 0 | 73,700 | -73,700 | |||
| Q3 2024 | 9,700 | 73,100 | 82,800 | 16,600 | 0 | 16,600 | 66,200 | |